1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31739
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCao, Zhipeng-
dc.contributor.authorBurvenich, Ingrid J-
dc.contributor.authorZhao, Kening-
dc.contributor.authorSenko, Clare-
dc.contributor.authorGlab, Jason-
dc.contributor.authorFogliaro, Renee-
dc.contributor.authorLiu, Zhanqi-
dc.contributor.authorJose, Irvin-
dc.contributor.authorPuthalakath, Hamsa-
dc.contributor.authorHoogenraad, Nick J-
dc.contributor.authorOsellame, Laura D-
dc.contributor.authorScott, Andrew M-
dc.date2022-
dc.date.accessioned2023-01-12T02:52:47Z-
dc.date.available2023-01-12T02:52:47Z-
dc.date.issued2022-11-10-
dc.identifier.citationCancers 2022; 14(22)en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31739-
dc.description.abstractDeveloping therapies for cancer cachexia has not been successful to date, in part due to the challenges of achieving robust quantitative measures as a readout of patient treatment. Hence, identifying biomarkers to assess the outcomes of treatments for cancer cachexia is of great interest and important for accelerating future clinical trials.en_US
dc.language.isoeng-
dc.subjectLCN2en_US
dc.subjectRNA-seqen_US
dc.subjectbiomarkeren_US
dc.subjectcancer cachexiaen_US
dc.titleIdentification of Potential Biomarkers for Cancer Cachexia and Anti-Fn14 Therapy.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleCancersen_US
dc.identifier.affiliationDepartment of Biochemistry and Genetics, La Trobe University, Melbourne, VIC 3086, Australia.en_US
dc.identifier.affiliationOlivia Newton-John Cancer Research Instituteen_US
dc.identifier.affiliationDepartment of Biochemistry and Genetics, La Trobe University, Melbourne, VIC 3086, Australia.en_US
dc.identifier.affiliationTumour Targeting Laboratory, Olivia Newton-John Cancer Research Institute, School of Cancer Medicine, La Trobe University, Melbourne, VIC 3084, Australia.en_US
dc.identifier.affiliationMolecular Imaging and Therapyen_US
dc.identifier.doi10.3390/cancers14225533en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0003-4142-6190en_US
dc.identifier.orcid0000-0001-8384-2403en_US
dc.identifier.orcid0000-0002-8039-8391en_US
dc.identifier.pubmedid36428623-
dc.description.volume14-
dc.description.issue22-
local.name.researcherScott, Andrew M
item.openairetypeJournal Article-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
crisitem.author.deptMedical Oncology-
crisitem.author.deptMolecular Imaging and Therapy-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

34
checked on Nov 29, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.